{"nct_id":"NCT05457010","title":"Phase I Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory AML or High-risk MDS","status":"RECRUITING","status_verified_date":"2023-11","start_date":"2022-11-28","start_date_type":"ACTUAL","primary_completion_date":"2025-09-30","primary_completion_date_type":"ESTIMATED","completion_date":"2025-11-17","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["ACLX"]}